Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 7/20 | 0.58 |
| ▸ | MAOA | P21397 | 4/20 | 0.58 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.53 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.50 |
| ▸ | SSTR3 | P32745 | 3/20 | 0.49 |
| ▸ | BCHE | P06276 | 2/20 | 0.49 |
| ▸ | ACHE | P22303 | 2/20 | 0.49 |
| ▸ | BACE1 | P56817 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 3/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2798417 | 1.00 | KDM1A (0.58) | KDM1AMAOAGRIN2BFUCA1SSTR3 | |
| SCHEMBL2936924 | 1.00 | KDM1A (0.58) | KDM1AMAOAGRIN2BFUCA1SSTR3 | |
| SCHEMBL2197651 | 1.00 | KDM1A (0.58) | KDM1AMAOAGRIN2BFUCA1SSTR3 | |
| SCHEMBL2198525 | 1.00 | KDM1A (0.58) | KDM1AMAOAGRIN2BFUCA1SSTR3 | |
| SCHEMBL2197644 | 1.00 | KDM1A (0.58) | KDM1AMAOAGRIN2BFUCA1SSTR3 | |
| Bromide SCHEMBL17822680 | 0.98 | KDM1A (0.56) | KDM1AMAOAGRIN2BFUCA1SSTR3 | |
| Bromide SCHEMBL16799767 | 0.98 | KDM1A (0.56) | KDM1AMAOAGRIN2BFUCA1SSTR3 | |
| Bromide SCHEMBL18129441 | 0.98 | KDM1A (0.56) | KDM1AMAOAGRIN2BFUCA1SSTR3 | |
| Ammonia Solution, Strong SCHEMBL2987109 | 0.98 | KDM1A (0.56) | KDM1AMAOAGRIN2BFUCA1SSTR3 | |
| Bromide SCHEMBL17822672 | 0.98 | KDM1A (0.56) | KDM1AMAOAGRIN2BFUCA1SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4086240-B1 | PYRROLIDINONE HERBICIDES | FMC CORP (US) | 2025-02-05 | — | — | EP | disclosed |
| US-12077525-B2 | Herbicidal compounds | SYNGENTA CROP PROTECTION AG (CH) | 2024-09-03 | — | — | US | disclosed |
| US-12077503-B2 | Substituted cyclic amides and their use as herbicides | FMC CORPORATION (US) | 2024-09-03 | — | — | US | disclosed |
| CN-118440059-A | Herbicidal mixtures | 先正达农作物保护股份公司 | 2024-08-06 | — | — | CN | disclosed |
| EP-3921307-B1 | PYRAZOLE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2024-06-26 | — | — | EP | disclosed |
| CN-114773400-B | Rhodium complex, preparation method, intermediate and application thereof | 中国科学院上海有机化学研究所 | 2024-04-26 | — | — | CN | disclosed |
| US-20240025853-A1 | SUBSTITUTED CYCLIC AMIDES AND THEIR USE AS HERBICIDES | FMC CORPORATION | 2024-01-25 | — | — | US | disclosed |
| US-11851420-B2 | Pyrazole derivatives | SYNGENTA CROP PROTECTION AG (CH) | 2023-12-26 | — | — | US | disclosed |
| CN-113423690-B | Pyrazole derivatives | 先正达农作物保护股份公司 | 2023-12-22 | — | — | CN | disclosed |
| US-11787765-B2 | Substituted cyclic amides and their use as herbicides | FMC CORPORATION (US) | 2023-10-17 | — | — | US | disclosed |
| EP-1765812-B1 | CONTRAST AGENTS ENDOWED WITH HIGH RELAXIVITY FOR USE IN MAGNETIC RESONANCE IMAGING (MRI) WHICH CONTAIN A CHELATING MOIETY WITH POLYHYDROXYLATED SUBSTITUENTS | BRACCO IMAGING SPA (IT) | 2009-04-29 | — | — | EP | disclosed |
| WO-2009000202-A1 | CHIRAL PHOSPHORAMIDES, CHIRAL N-PHOSPHONIMINES AND METHODS FOR FORMING THE SAME | NOWA PHARMACEUTICALS CO., LTD (CN) | 2008-12-31 | — | — | WO | disclosed |
| WO-2006136564-A9 | MULTIDENTATE AZA LIGANDS ABLE TO COMPLEX METAL IONS AND THE USE THEREOF IN DIAGNOSTICS AND THERAPY | BRACCO IMAGING SPA (IT) | 2008-02-07 | — | — | WO | disclosed |
| WO-2008003809-A1 | ANTITUMOUR COMPOUNDS | PHARMA MAR, S.A. (ES) | 2008-01-10 | — | — | WO | disclosed |
| US-20070258905-A1 | Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents | BRACCO IMAGING SPA (IT) | 2007-11-08 | — | — | US | disclosed |
| US-20070258905-A1 | Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents | BRACCO IMAGING SPA (IT) | 2007-11-08 | — | — | US | disclosed |
| US-20060034773-A1 | Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy | BRACCO IMAGING SPA (IT) | 2006-02-16 | — | — | US | disclosed |
| EP-0558656-B1 | NEW METHODS FOR THE CATALYTIC REDUCTION OF ORGANIC SUBSTRATES | MASSACHUSETTS INST TECHNOLOGY (US) | 1996-04-17 | — | — | EP | disclosed |
| EP-0558656-A1 | NEW METHODS FOR THE CATALYTIC REDUCTION OF ORGANIC SUBSTRATES. | MASSACHUSETTS INST TECHNOLOGY (US) | 1993-09-08 | — | — | EP | disclosed |
| WO-1992009545-A2 | NEW METHODS FOR THE CATALYTIC REDUCTION OF ORGANIC SUBSTRATES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1992-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11851420-B2 | Pyrazole derivatives | RB1, CBR3, CYP1B1 | KDM1A 257/4885MAOA 2766/4885GRIN2B 1426/4885 |
| US-20060034773-A1 | Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy | SSTR3, MB, CA13 | KDM1A 3387/4885MAOA 409/4885GRIN2B 521/4885 |
| US-12077525-B2 | Herbicidal compounds | DDT, ACHE, CAT | KDM1A 1090/4885MAOA 824/4885GRIN2B 265/4885 |
| US-11787765-B2 | Substituted cyclic amides and their use as herbicides | NIT2, ARG1, CNPY2 | KDM1A 796/4885MAOA 1121/4885GRIN2B 1289/4885 |
| US-20240025853-A1 | SUBSTITUTED CYCLIC AMIDES AND THEIR USE AS HERBICIDES | NIT2, ARG1, CNPY2 | KDM1A 801/4885MAOA 1104/4885GRIN2B 1290/4885 |
| US-12077503-B2 | Substituted cyclic amides and their use as herbicides | NIT2, ARG1, CNPY2 | KDM1A 801/4885MAOA 1104/4885GRIN2B 1290/4885 |
| US-20070258905-A1 | Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents | RXFP1, SLC5A7, SLC40A1 | KDM1A 600/4885MAOA 2299/4885GRIN2B 2885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.